These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35456030)

  • 1. Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model.
    Westmark CJ; Filon MJ; Maina P; Steinberg LI; Ikonomidou C; Westmark PR
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Soy Protein Isolate on Fragile X Phenotypes in Mice.
    Westmark PR; Lyon G; Gutierrez A; Boeck B; Van Hammond O; Ripp N; Pagan-Torres NA; Brower J; Held PK; Scarlett C; Westmark CJ
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical testing of the ketogenic diet in fragile X mice.
    Westmark PR; Gutierrez A; Gholston AK; Wilmer TM; Westmark CJ
    Neurochem Int; 2020 Mar; 134():104687. PubMed ID: 31958482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
    Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
    Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Inception of Ketogenic Diet Therapy Increases Sleep during the Dark Cycle in C57BL/6J Wild Type and Fragile X Mice.
    Westmark PR; Swietlik TJ; Runde E; Corsiga B; Nissan R; Boeck B; Granger R; Jennings E; Nebbia M; Thauwald A; Lyon G; Maganti RK; Westmark CJ
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome.
    Westmark CJ; Kniss C; Sampene E; Wang A; Milunovich A; Elver K; Hessl D; Talboy A; Picker J; Haas-Givler B; Esler A; Gropman AL; Uy R; Erickson C; Velinov M; Tartaglia N; Berry-Kravis EM
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model.
    Ma M; Yu Q; Delafield DG; Cui Y; Li Z; Li M; Wu W; Shi X; Westmark PR; Gutierrez A; Ma G; Gao A; Xu M; Xu W; Westmark CJ; Li L
    ACS Chem Neurosci; 2024 Jan; 15(1):119-133. PubMed ID: 38109073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
    Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
    Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
    Dansie LE; Phommahaxay K; Okusanya AG; Uwadia J; Huang M; Rotschafer SE; Razak KA; Ethell DW; Ethell IM
    Neuroscience; 2013 Aug; 246():186-98. PubMed ID: 23660195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome.
    Padmashri R; Reiner BC; Suresh A; Spartz E; Dunaevsky A
    J Neurosci; 2013 Dec; 33(50):19715-23. PubMed ID: 24336735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.
    Mines MA; Yuskaitis CJ; King MK; Beurel E; Jope RS
    PLoS One; 2010 Mar; 5(3):e9706. PubMed ID: 20300527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses.
    Spencer CM; Alekseyenko O; Hamilton SM; Thomas AM; Serysheva E; Yuva-Paylor LA; Paylor R
    Autism Res; 2011 Feb; 4(1):40-56. PubMed ID: 21268289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral Phenotype of Fmr1 Knock-Out Mice during Active Phase in an Altered Light/Dark Cycle.
    Saré RM; Levine M; Smith CB
    eNeuro; 2016; 3(2):. PubMed ID: 27294193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
    Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T
    Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.